Faraz Accelerator has signed an agreement with HamSan Baft Adli to support the development of personalized orthopedic prosthetics through financial investment and strategic guidance.
Target Company Overview
The company, HamSan Baft Adli, is a knowledge-based enterprise established in 2022 with the objective of translating laboratory research findings into clinical applications for treating bone tissue defects. The primary focus of the company is on developing customized prosthetics designed to repair facial and jaw abnormalities using patients' CT scan images. To date, the company has successfully produced over 20 clinical samples of its first-generation prosthetic products.
Every year, a significant number of patients in Iran and worldwide suffer from bone-related accidents requiring surgical interventions. The type of treatment necessary depends on the severity and nature of the injuries sustained. One prevalent solution for the restoration of damaged tissues is the use of bone prostheses, which are sometimes the only clinically viable option based on the severity of the injury.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Iran
The orthopedic medical device industry in Iran has been growing steadily due to rising healthcare demands driven by an increasing population and higher rates of accidents. Innovations within this sector are primarily focused on improving the quality and customizat
Similar Deals
Boston Scientific → Nalu Medical
2026
Barça Innovation Hub → Omniscope
2025
Otsuka Pharmaceutical Co., Ltd. → 4D Molecular Therapeutics
2025
Cressey & Company LP → Paradigm Health
2025
Fraz Accelerator
invested in
Hamsan Baft Adli
in 2024
in a Strategic Partnership deal